Matthew Link's Insider Trades & SAST Disclosures
Matthew Link's most recent trade in Sight Sciences Inc was a trade of 5,042 Common Stock done at an average price of $2.3 . Disclosure was reported to the exchange on April 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Matthew Link.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sight Sciences Inc | Matthew Link | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 02 Apr 2025 | 5,042 | 830,551 | - | 2.3 | 11,642 | Common Stock |
| Sight Sciences Inc | Matthew Link | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 172,043 | 835,593 | - | 0 | Common Stock | |
| Sight Sciences Inc | Matthew Link | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.61 per share. | 18 Oct 2024 | 21,831 | 663,550 | - | 5.6 | 122,450 | Common Stock |
| Sight Sciences Inc | Matthew Link | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.98 per share. | 18 Oct 2024 | 20,487 | 685,381 | - | 6.0 | 122,451 | Common Stock |
| Sight Sciences Inc | Matthew Link | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.84 per share. | 16 Oct 2024 | 20,970 | 705,868 | - | 5.8 | 122,444 | Common Stock |
| Sight Sciences Inc | Matthew Link | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.90 per share. | 16 Oct 2024 | 20,734 | 726,838 | - | 5.9 | 122,434 | Common Stock |
| FibroBiologics Inc | Matthew Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges